Veterinary Medicines

DEROXEN Schiuma Spray, 4 mg/ml schiuma cutanea per cani e gatti

Authorised
  • CHLORHEXIDINE DIGLUCONATE SOLUTION
  • Allantoin
  • Alpha-bisabolol
Download as PDF

Product identification

Medicine name:
DEROXEN Schiuma Spray, 4 mg/ml schiuma cutanea per cani e gatti
Active substance:
  • CHLORHEXIDINE DIGLUCONATE SOLUTION
  • Allantoin
  • Alpha-bisabolol
Target species:
  • Dog
  • Cat
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • CHLORHEXIDINE DIGLUCONATE SOLUTION
    0.71
    gram(s)
    /
    100.00
    millilitre(s)
  • Allantoin
    0.40
    gram(s)
    /
    100.00
    millilitre(s)
  • Alpha-bisabolol
    1.00
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Cutaneous foam
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD08AC52
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Teknofarma S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Teknofarma S.r.l.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 102468
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 20/01/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."